Friday, July 10, 2026

biotech · Essential Tremor · Systemic Lupus Erythematosus

Chongqing Precision Biotech

Chongqing Precision Biotech is a biotech organization headquartered in Chongqing, CN. Primary therapeutic focus areas include Essential Tremor, Systemic Lupus Erythematosus, Focal Epilepsy, Multiple Myeloma, Colorectal C

重庆市创业大道高科创业园A栋, Chongqing, CN HQ
2016 Founded
5 Employees
NMPA registrant Type
Company details
Status
Public
HQ
重庆市创业大道高科创业园A栋, Chongqing, CN
Founded
2016
Employees
5
Programs
109
Drugs
57
Patents
158
Clinical program

PBCAR19B

Phase 1 · gene therapy · CD19 Expressing Malignancies

PBCAR19B for CD19 Expressing Malignancies is a Phase 1 program (gene_therapy) at Chongqing Precision Biotech Co., Ltd with 1 ClinicalTrials.gov record(s).

Internal code PBCAR19B-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Chongqing Precision Biotech Co., Ltd
Phase
Phase 1
Modality
gene_therapy
Indication
CD19 Expressing Malignancies
Status
completed
Trials
1

Clinical trials